Tapentadol for Neuropathic Pain: a Review of Clinical Studies
Overview
Affiliations
Neuropathic pain (NP) is an enormous burden for patients, caregivers and society. NP is a pain state that may develop after injury of the peripheral or central nervous system because of a wide range of diseases and traumas. A NP symptom component can be found also in several types of chronic pain. Many NP patients are substantially disabled for years. Due to its chronicity, severity and unpredictability, NP is difficult to treat. Tapentadol is a central-acting oral analgesic with combined opioid and noradrenergic properties, which make it potentially suitable for a wide range of pain conditions, particularly whenever a NP component is present or cannot be excluded. In randomized controlled trials, tapentadol has proved to be effective in relieving NP in diabetic peripheral neuropathy and in chronic low back pain. In observational studies, tapentadol reduced NP in chemotherapy-induced peripheral neuropathies, blood and solid cancers, and the NP component in neck pain and Parkinson's disease. This narrative review aims to provide clinicians with a broad overview of tapentadol effects on NP.
Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment.
Manengu C, Zhu C, Zhang G, Tian M, Lan X, Tao L Curr Neuropharmacol. 2024; 23(3):276-294.
PMID: 39411936 PMC: 11808587. DOI: 10.2174/1570159X23666241011163035.
Opioid system and related ligands: from the past to future perspectives.
Rullo L, Morosini C, Lacorte A, Cristani M, Coluzzi F, Candeletti S J Anesth Analg Crit Care. 2024; 4(1):70.
PMID: 39390585 PMC: 11468104. DOI: 10.1186/s44158-024-00201-2.
Sex-Gender Differences Are Completely Neglected in Treatments for Neuropathic Pain.
Salis F, Sardo S, Finco G, Gessa G, Franconi F, Agabio R Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065689 PMC: 11280170. DOI: 10.3390/ph17070838.
Assessment for Diabetic Neuropathy: Treatment and Neurobiological Perspective.
Bhrigu B, Sharma S, Kumar N, Banik B Curr Diabetes Rev. 2024; 21(6):12-31.
PMID: 38798207 DOI: 10.2174/0115733998290606240521113832.
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain.
De Rosa F, Giannatiempo B, Charlier B, Coglianese A, Mensitieri F, Gaudino G Pharmaceutics. 2023; 15(8).
PMID: 37631302 PMC: 10457775. DOI: 10.3390/pharmaceutics15082088.